The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Calciup D3 500 mg/440 IU chewable tablet

Rowex LtdPA0711/217/002

Main Information

Trade NameCalciup D3 500 mg/440 IU chewable tablet
Active SubstancesCalcium carbonate
Cholecalciferol concentrate
Dosage FormChewable tablet
Licence HolderRowex Ltd
Licence NumberPA0711/217/002

Group Information

ATC CodeA12AX Calcium, combinations with vitamin D and/or other drugs


License statusAuthorised
Licence Issued01/08/2014
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back